-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BzXvGXuwnQyuNW4j8VP+6s2o6MncYWmAF7fI3aFk53ErbBijWrIPAzGKUcnB3axB 2jBBhXA7ILBCbQn+t9TNyw== 0000898432-09-000185.txt : 20090213 0000898432-09-000185.hdr.sgml : 20090213 20090213160712 ACCESSION NUMBER: 0000898432-09-000185 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090213 DATE AS OF CHANGE: 20090213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AUTOIMMUNE INC CENTRAL INDEX KEY: 0000879106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133489062 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44757 FILM NUMBER: 09603487 BUSINESS ADDRESS: STREET 1: 1199 MADIA STREET CITY: PASADENA STATE: CA ZIP: 91103 BUSINESS PHONE: 6267921235 MAIL ADDRESS: STREET 1: 1199 MADIA STREET CITY: PASADENA STATE: CA ZIP: 91103 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ANDREEFF EQUITY ADVISORS, LLC CENTRAL INDEX KEY: 0001317097 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 450 LAUREL STREET STREET 2: SUITE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 BUSINESS PHONE: 225-706-1600 MAIL ADDRESS: STREET 1: 450 LAUREL STREET STREET 2: SUITE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 SC 13G/A 1 andreeff-sc13ga.htm



SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

SCHEDULE 13G/A
(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)

(Amendment No. 3)

Autoimmune Inc.

(Name of Issuer)
 

Common Stock

(Title of Class of Securities)

 

052776101

(CUSIP Number)

 

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 

o    Rule 13d-1(b)
x   Rule 13d-1(c)
o    Rule 13d-1(d)

          *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


          The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

  

CUSIP No. 052776101

 

13G/A

 

Page 2 of 6 Pages

  

  

 

1

 

 

NAME OF REPORTING PERSON:
Andreeff Equity Advisors, L.L.C.

 

 
 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)   o

 

 

 

 

(b)  x

 

 

 

 

 
 

3

 

SEC USE ONLY

 

 

 

 

 

 

 
 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

Delaware

 

 
 

 

 

5

 

SOLE VOTING POWER

NUMBER OF

 

 

 

0

SHARES

 

  

BENEFICIALLY

 

6

 

SHARED VOTING POWER

OWNED

 

 

  

1,367,468

BY

 

  

EACH

 

7

 

SOLE DISPOSITIVE POWER

REPORTING

 

 

 

0

PERSON

 

  

WITH:

 

8

 

SHARED DISPOSITIVE POWER

 

 

 

 

1,367,468
 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

 

1,367,468

 

 
 

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

o

 

 

 

 

 
 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

 

 

8.04%

 

 
 

12

 

TYPE OF REPORTING PERSON*

 

 
 

 

IA, CO

    

 

 

 

 

  

CUSIP No. 052776101

 

13G/A

 

Page 3 of 6 Pages
 
 

1

 

NAME OF REPORTING PERSON:
Dane Andreeff

 

 
 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 

(a)   o

 

 

 

 

(b)  x

 

 

 

 

 
 

3

 

SEC USE ONLY

 

 

 

 

 

 

 
 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

 

 

Canada

 

 
 

 

 

5

 

SOLE VOTING POWER

NUMBER OF

 

 

 

0

SHARES

 

  

BENEFICIALLY

 

6

 

SHARED VOTING POWER

OWNED

 

 

 

1,367,468

BY

 

  

EACH

 

7

 

SOLE DISPOSITIVE POWER

REPORTING

 

 

 

0

PERSON

 

  

WITH:

 

8

 

SHARED DISPOSITIVE POWER

 

 

 

 

1,367,468
 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

 

1,367,468

 

 
 

10

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

o

 

 

 

 

 

     

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

 

 

 

8.04%

 

 
 

12

 

TYPE OF REPORTING PERSON*

 

 
 

 

IN, HC

    

 

 

 

 

  

CUSIP No. 052776101

 

13G/A

 

Page 4 of 6 Pages
 

 

 

 

  

ITEM 1(a).      NAME OF ISSUER:


                         Autoimmune Inc.


ITEM 1(b).      ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

                              1199 Madia Street

                              Pasadena, CA 91103
          

ITEM 2(a).      NAME OF PERSON FILING:

                         This Schedule 13G/A is being filed on behalf of the following persons (the “Reporting Persons”):

 

(i)

 

Andreeff Equity Advisors, L.L.C. (“AEA”)

 

(ii)

 

Dane Andreeff

 

ITEM 2(b).      ADDRESS OF PRINCIPAL BUSINESS OFFICE:


                         The principal business office of the Reporting Persons filing this Schedule 13G/A is located at 140 East St. Lucia Lane, Santa Rosa Beach, FL 32459.


ITEM 2(c).      CITIZENSHIP:

 

(i)

AEA:

a Delaware limited liability company
 

(ii)

Dane Andreeff:

Canada


ITEM 2(d).      TITLE OF CLASS OF SECURITIES:

                               Common Stock

ITEM 2(e).      CUSIP Number:

                               052776101





 

 

 

 

  

CUSIP No. 052776101

 

13G/A

 

Page 5 of 6 Pages
 

 

 

 

  

ITEM 3.        IF THIS STATEMENT IS FILED PURSUANT TO RULE 13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS:    One of the following

                        Not applicable.


ITEM 4.        OWNERSHIP:


                        The information in items 1 and 5 through 11 on the cover pages (pp. 2-3) on this Schedule 13G is hereby incorporated by reference.


ITEM 5.        OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:


                        If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities check the following.     o


ITEM 6.        OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:


                        Not applicable.


ITEM 7.        IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:


     Mr. Andreeff is the Managing Member of Andreeff Equity Advisors, L.L.C. (“AEA”) and Maple Leaf Capital I, L.L.C. (“Capital”). AEA is the Investment Adviser and Capital is the General Partner of the following limited partnerships, each of which owns less than 5% of the issuer’s securities:

   

(i) Maple Leaf Partners, L.P.
   

(ii) Maple Leaf Partners I, L.P.
   

(iii) Maple Leaf Discovery, L.P.
   

(iv) Maple Leaf Discovery I, L.P.

          AEA is the Investment Adviser and Mr. Andreeff is the Director of Maple Leaf Offshore, Ltd. and Maple Leaf Discovery Offshore, Ltd., each of which owns less than 5% of the issuer’s securities.

ITEM 8.        IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP:


                        Not applicable.


ITEM 9.        NOTICE OF DISSOLUTION OF GROUP:


                        Not applicable.

 

 

 

 

  

CUSIP No. 052776101

 

13G/A

 

Page 6 of 6 Pages
 

 

 

 

  

ITEM 10.        CERTIFICATION


                        By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

                        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:

 

February 13, 2009

 


/s/ Dane Andreeff
_________________________________
Dane Andreeff *

  
     
 

ANDREEFF EQUITY ADVISORS, L.L.C.*
By: Dane Andreeff

  
     
 

 

/s/ Dane Andreeff
_________________________________
Name: Dane Andreeff
Title: Managing Member

  

* The Reporting Persons disclaim beneficial ownership in the shares reported herein except to the extent of their pecuniary interest therein.

EXHIBIT A

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a statement on Schedule 13G and all amendments thereto with respect to the Common Stock of Autoimmune Inc. beneficially owned by each of them, and the inclusion of this Joint Filing Agreement as an exhibit thereto.

 

Dated: February 13, 2009
 
 
 
/s/ Dane Andreeff
_______________________________
Dane Andreeff

  

  

    

  

    

  

    
 

ANDREEFF EQUITY ADVISORS, L.L.C.

By: Dane Andreeff


/s/ Dane Andreeff
_______________________________

Name: Dane Andreeff

Title: Managing Member

  


 

 

 

 

 

 

 

 

 

 -----END PRIVACY-ENHANCED MESSAGE-----